Dyne Therapeutics Inc (DYN)

14.23 -0.19  -1.32% NASDAQ Oct 20, 15:54 USD

Dyne Therapeutics Cash from Investing (TTM):

-180.19M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -180.19M
March 31, 2021 -173.82M
Dec. 31, 2020 -45.66M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Veracyte Inc -576.66M
Moderna Inc -5.427B
BridgeBio Pharma Inc -243.63M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -180.19M Jun 2021
Maximum -45.66M Dec 2020
Average -133.22M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.